MedPath

PRO Gel 5000

Gel 5000

Approved
Approval ID

f127e236-5207-948b-e053-2a95a90ab740

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 31, 2024

Manufacturers
FDA

DENTAL ALLIANCE HOLDINGS LLC

DUNS: 195544965

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sodium fluoride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61578-216
Product Classification
G
Generic Name
Sodium fluoride
Product Specifications
Route of AdministrationDENTAL
Effective DateJanuary 31, 2024
FDA Product Classification

INGREDIENTS (15)

MALTITOLInactive
Code: D65DG142WK
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYDRATED SILICAInactive
Code: Y6O7T4G8P9
Classification: IACT
HYDROXYETHYL CELLULOSE (3000 CPS AT 1%)Inactive
Code: 7Q6P4JN1QT
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
SACCHARINInactive
Code: FST467XS7D
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
TRIBASIC CALCIUM PHOSPHATEInactive
Code: 91D9GV0Z28
Classification: IACT
POLYSORBATE 20Inactive
Code: 7T1F30V5YH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT
SODIUM FLUORIDEActive
Quantity: 5000 ug in 1 g
Code: 8ZYQ1474W7
Classification: ACTIM

Sodium fluoride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code61578-215
Product Classification
G
Generic Name
Sodium fluoride
Product Specifications
Route of AdministrationDENTAL
Effective DateJanuary 31, 2024
FDA Product Classification

INGREDIENTS (16)

MALTITOLInactive
Code: D65DG142WK
Classification: IACT
TRIBASIC CALCIUM PHOSPHATEInactive
Code: 91D9GV0Z28
Classification: IACT
POTASSIUM SORBATEInactive
Code: 1VPU26JZZ4
Classification: IACT
MENTHOLInactive
Code: L7T10EIP3A
Classification: IACT
HYDROXYETHYL CELLULOSE (3000 CPS AT 1%)Inactive
Code: 7Q6P4JN1QT
Classification: IACT
POLYSORBATE 20Inactive
Code: 7T1F30V5YH
Classification: IACT
SACCHARINInactive
Code: FST467XS7D
Classification: IACT
SODIUM BICARBONATEInactive
Code: 8MDF5V39QO
Classification: IACT
SODIUM BENZOATEInactive
Code: OJ245FE5EU
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
SODIUM FLUORIDEActive
Quantity: 5000 ug in 1 g
Code: 8ZYQ1474W7
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
XYLITOLInactive
Code: VCQ006KQ1E
Classification: IACT
GLYCERINInactive
Code: PDC6A3C0OX
Classification: IACT
HYDRATED SILICAInactive
Code: Y6O7T4G8P9
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 5/10/2022

PRO Gel 5000 Mint and Citrus enclosure and carton labels:

Box Principle Display PanelBox Principle Display PanelTube Principle Display PanelTube Principle Display Panel

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/8/2014

Indications and Use:

A dental caries preventive; for once daily self-applied topical use. It is well established that a 1.1% sodium fluoride is safe and extraordinarily effective as a caries preventive when applied frequently with mouthpiece applicators.1-4 CariFree CTx4 Gel 5000 brand of 1.1% sodium fluoride toothpaste in a squeeze tube is easily applied onto a toothbrush as well as a mouthpiece tray. This prescription dental gel should be used once daily following use of a regular toothpaste unless otherwise instructed by your dental professional. May be used in areas where drinking water is fluoridated since topical fluoride cannot produce fluorosis. (See Warnings for exception)

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 1/8/2014

Contraindications:

Do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 1/8/2014

Adverse Reactions:

Allergic reactions and other idiosyncrasies have been rarely reported.

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

LOINC: 34083-6Updated: 1/8/2014

Carcinogenesis, Mutagenesis, Impairment of Fertility:

In a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. Equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. In a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. Epidemiological data provided no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer.
Fluoride is not mutagenic in standard bacterial systems. It has been shows that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. In vivo data are conflicting. Some studies report chromosome damage in rodents, while other studies using similar protocols report negative results.
Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.

INACTIVE INGREDIENT SECTION

LOINC: 51727-6Updated: 1/8/2014

Other Ingredients:

Glycerin, Hydrated Silica, Hydrogenated Starch Hydrolysate (HSH), Hydroxyapatite, Hydroxyethyl Cellulose, Natural Flavors (Mint only), Natural and Artificial Flavors (Citrus only), Polysorbate 20, Potassium Sorbate, Saccharin, Sodium Benzoate, Sodium Bicarbonate, Sodium Hydroxide, Sodium Lauryl Sulfate, Water, Xylitol

DESCRIPTION SECTION

LOINC: 34089-3Updated: 1/8/2014

Description:

Self-topical neutral fluoride gel containing 1.1% sodium fluoride for use as a dental caries preventive in adults and pediatric patients.

OTC - ACTIVE INGREDIENT SECTION

LOINC: 55106-9Updated: 1/8/2014

Active Ingredient:

Sodium Fluoride, 1.1% (w/w)

CLINICAL PHARMACOLOGY SECTION

LOINC: 34090-1Updated: 1/8/2014

Clinical Pharmacology:

Frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into the tooth structure.

WARNINGS SECTION

LOINC: 34071-1Updated: 1/8/2014

Warnings:

Prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under age 6 years, especially if water fluoridation exceeds 0.6 ppm. Use in pediatric patients under age 6 years requires special supervision to prevent repeated swallowing of gel. Read directions carefully before using. Keep out of reach of infants and children.

PRECAUTIONS SECTION

LOINC: 42232-9Updated: 1/8/2014

Precautions:

General: Not for systemic treatments. DO NOT SWALLOW.

PREGNANCY SECTION

LOINC: 42228-7Updated: 1/8/2014

Pregnancy:

Pregnancy Category B. It has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. Animal studies (rats, mice, rabbits) have shown that fluoride is not teratogen. Maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. There are no adequate and well-controlled studies in pregnant women. However, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. Heavy exposure to fluoride during in utero development may result in skeletal fluorosis, which becomes evident in childhood.

NURSING MOTHERS SECTION

LOINC: 34080-2Updated: 1/8/2014

Nursing Mothers:

It is not known if fluoride is excreted in human milk. However, many drugs are excreted in milk, and caution should be exercised when products containing fluoride are administered to a nursing woman. Reduce milk production was reported in farm-raised fox when the animals were fed a diet containing a high concentration of fluoride (98-137 mg/kg of body weight). No adverse effects on parturition, lactation, or offspring were seen in rats administered fluoride up to 5 mg/kg of body weight.

PEDIATRIC USE SECTION

LOINC: 34081-0Updated: 1/8/2014

Pediatric Use:

The use of CariFree CTx4 Gel 5000 in pediatric age group 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11 to 14 years conducted by Englander et al.2-4 Safety and effectiveness in pediatric patients below the age of 6 years have not been established. Please refer to Contraindications andWarnings sections.

OVERDOSAGE SECTION

LOINC: 34088-5Updated: 1/8/2014

Overdosage:

Accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. Nauseau, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. These symptoms may persist for 24 hours. If less than 5 mg fluoride/kg body weight (ie, less than 2.3 mg fluoride/lb body weight) have been ingested, give calcium (eg, milk) orally to relieve gastrointestinal symptoms and observe for a few hours. If more than 5 mg fluoride/kg body weight (ie, more than 2.3 mg fluoride/lb body weight) have been ingested, induce vomiting, give orally soluble calcium (eg, milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. For accidental ingestion of more than 15 mg fluoride/kg of body weight (ie, more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility.
A treatment dose (a thin ribbon) of CariFree CTx4 Gel 5000 contains 2.5 mg fluoride. A 2 oz tube contains 284 mg fluoride.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/8/2014

Dosage and Administration:

Follow these instructions unless otherwise instructed by your dental professional:
1. After brushing with toothpaste, adults and pediatric patients 6 years of age and older, apply a thin ribbon of gel to the teeth with a toothbrush for at least one minute, preferably at bedtime.
2. Adult patients, expectorate gel after use. For best results, do not eat, drink or rinse for 30 minutes. Pediatric patients, age 6-16, expectorate gel after use and rinse mouth thoroughly.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 1/8/2014

How Supplied:

2 oz (56.699g) tube.

NDC# 61578-205-01 (Mint)

NDC# 61578-206-01 (Citrus)

STORAGE AND HANDLING SECTION

LOINC: 44425-7Updated: 1/8/2014

Storage:

Store at controlled room temperature, 20-25° C (68-77°F)

REFERENCES SECTION

LOINC: 34093-5Updated: 1/8/2014

References:

1. American Dental Association, Accepted Dental Therapeutics, Ed 40, Chicago (1984): 405-407.
2. HR Englander et al, “Clinical Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces,” JADA, 75 (1967): 638-644.
3. HR Englander et al, “Residual Anticaries Effect of Repeated Topical Sodium Fluoride Applications by Mouthpieces,” JADA, 78 (1969): 783-787.
4. HR Englader et al, “Incremental Rates of Dental Caries After Repeated Topical Sodium Fluoride
Applications in Children with Lifelong Consumption of Fluoridated Water,” JADA, 82 (1971): 354-358.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PRO Gel 5000 - FDA Drug Approval Details